BioCentury
ARTICLE | Clinical News

Savaysa: Phase IIIb data

September 12, 2016 7:00 AM UTC

Daiichi Sankyo Co. Ltd. (Tokyo:4568), Tokyo, Japan Product: Savaysa ( Lixiana - EU) edoxaban (DU-176b) Business: Cardiovascular Molecular target: Factor Xa Description: Oral Factor Xa inhibitor Indica...